Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis

被引:22
|
作者
Khac-Dung Nguyen [1 ,2 ,3 ]
Thuy-Ngan Tran [1 ]
Nguyen, Mai-Loan T. [1 ]
Hoang-Anh Nguyen [1 ]
Hoang-Anh Nguyen [1 ]
Dinh-Hoa Vu [1 ]
Van-Doan Nguyen [4 ]
Bagheri, Haleh [2 ,3 ]
机构
[1] Hanoi Univ Pharm, Natl Ctr Drug Informat & Adverse Drug React Monit, Hanoi, Vietnam
[2] Paul Sabatier Univ, Fac Med, Med & Clin Pharmacol Lab, Toulouse, France
[3] Toulouse Univ, Hosp Ctr, UMR INSERM 1027, Midi Pyrenees Ctr Pharmacovigilance Pharmacoepide, Toulouse, France
[4] Bach Mai Hosp, Ctr Allergol & Clin Immunol, Hanoi, Vietnam
关键词
drug safety; signal generation; Stevens-Johnson syndrome; toxic epidermal necrosis; Vietnamese spontaneous reporting database; HLA-B-ASTERISK-1502; ALLELE; BIAS; EPIDEMIOLOGY; ALLOPURINOL; ASSOCIATION; SYSTEM;
D O I
10.1111/jcpt.12754
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and objective Despite the numerous studies investigating drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), the understanding and quantitative data in developing countries remain limited. The study aimed to describe and quantify the drug-related risk of SJS/TEN in a resource-limited context using the Vietnamese spontaneous reporting database (VSRD) of adverse drug reactions. Methods Spontaneous reports relating to medium- and late-onset severe cutaneous adverse reactions (MLOSCAR) and SJS/TEN recorded in the VSRD from 2010 to 2015 were retrospectively analysed. The demographic characteristics and drug information were described and compared between SJS/TEN and other MLOSCAR reports. The drug-induced SJS/TEN signals were estimated using subgrouped disproportionality analysis with calculation of the reporting odds ratio (ROR) and the respective 95% confidence interval (CI). Results The VSRD received 2,849 MLOSCAR reports, 136 of which focus on SJS/TEN over a 6-year period. About 60% of SJS/TEN patients were male, and the majority of them were adults (mean age 42.5 +/- 22.9). Up to 91.8% of drugs induced SJS/TEN within 1-28 days, and 45% SJS/TEN cases were evaluated as life-threatening. Positive signals were generated with carbamazepine (n = 25, ROR [95% CI] = 11.99 [7.07-19.92]), allopurinol (n = 15, ROR [95% CI] = 4.2 [2.20-7.59]), traditional/herbal medicines (n = 7, ROR [95% CI] = 2.76 [1.12-5.86]), colchicine (n = 4, ROR [95% CI] = 6.22 [1.69-18.72]), valproic acid (n = 3, ROR [95% CI] = 8.71 [1.89-30.19]) and meloxicam (n = 3, ROR [95% CI] = 7.09 [1.55-24.29]), which are well known for SJS/TEN. Cefixime (n = 5, ROR [95% CI] = 3.34 [1.13-8.00]) and paracetamol (n = 22, ROR [95% CI] = 5.23 [3.10-8.49]) also generated positive signals despite their popularity in Vietnam. What is new and conclusion This first Vietnamese population-based study has highlighted original characteristics and signals of drug-induced SJS/TEN, which are relatively consistent with other worldwide data and typical for a developing country.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 50 条
  • [21] Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital
    Techasatian, Leelawadee
    Panombualert, Sunee
    Uppala, Rattapon
    Jetsrisuparb, Charoon
    WORLD JOURNAL OF PEDIATRICS, 2017, 13 (03) : 255 - 260
  • [22] Retrospective review of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution
    Sibbald, Cathryn
    Putterman, Elana
    Micheletti, Robert
    Treat, James
    Castelo-Soccio, Leslie
    PEDIATRIC DERMATOLOGY, 2020, 37 (03) : 461 - 466
  • [23] Stevens-Johnson syndrome/toxic epidermal necrolysis and erythema multiforme drug-related hospitalisations in a national administrative database
    Sousa-Pinto, Bernardo
    Araujo, Luis
    Freitas, Alberto
    Correia, Osvaldo
    Delgado, Luis
    CLINICAL AND TRANSLATIONAL ALLERGY, 2018, 8
  • [24] Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital
    Leelawadee Techasatian
    Sunee Panombualert
    Rattapon Uppala
    Charoon Jetsrisuparb
    World Journal of Pediatrics, 2017, 13 : 255 - 260
  • [25] Drug patch testing in Stevens-Johnson syndrome and toxic epidermal necrolysis A systematic review
    Novack, Danielle E.
    Braskett, Melinda
    Worswick, Scott D.
    Adler, Brandon L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (05) : 628 - 636
  • [26] Internet Accounts of Serious Adverse Drug ReactionsA Study of Experiences of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Tehreem F. Butt
    Anthony R. Cox
    Jan R. Oyebode
    Robin E. Ferner
    Drug Safety, 2012, 35 : 1159 - 1170
  • [27] Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis
    Wolkenstein, P
    Chosidow, O
    Flechet, ML
    Robbiola, O
    Paul, M
    Dume, L
    Revuz, J
    Roujeau, JC
    CONTACT DERMATITIS, 1996, 35 (04) : 234 - 236
  • [28] Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System
    Borrelli, Eric P.
    Lee, Erica Y.
    Descoteaux, Andrew M.
    Kogut, Stephen J.
    Caffrey, Aisling R.
    EPILEPSIA, 2018, 59 (12) : 2318 - 2324
  • [29] Oseltamivir induced Stevens-Johnson syndrome/toxic epidermal necrolysis-case report
    Zuo, Wei
    Wen, Li-Ping
    Li, Jun
    Mei, Dan
    Fu, Qiang
    Zhang, Bo
    MEDICINE, 2019, 98 (19)
  • [30] Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese
    Hung, Shuen-Iu
    Chung, Wen-Hung
    Liu, Zhi-Sheng
    Chen, Chien-Hsiun
    Hsih, Mo-Song
    Hui, Rosaline Chung-yee
    Chu, Chia-Yu
    Chen, Yuan-Tsong
    PHARMACOGENOMICS, 2010, 11 (03) : 349 - 356